How does VERV's 2024 performance compare to forecasts?

Verve Therapeutics (VERV) experienced a closing price of $5.64 on December 29, 2024, and December 31, 2024, which is slightly below the average forecasted price for the year. This indicates that the stock's performance was somewhat lower than anticipated, suggesting potential challenges or setbacks for the company in the period. |code|Ticker|Name|Date|Closing Price|market_code| |---|---|---|---|---|---| |VERV|VERV.O|Verve Therapeutics|20240102|14|185| |VERV|VERV.O|Verve Therapeutics|20240103|13|185| |VERV|VERV.O|Verve Therapeutics|20240104|13.61|185| |VERV|VERV.O|Verve Therapeutics|20240105|13.32|185| |VERV|VERV.O|Verve Therapeutics|20240108|13.93|185| |VERV|VERV.O|Verve Therapeutics|20240109|13.92|185| |VERV|VERV.O|Verve Therapeutics|20240110|13.79|185| |VERV|VERV.O|Verve Therapeutics|20240111|13.01|185| |VERV|VERV.O|Verve Therapeutics|20240112|12.77|185| |VERV|VERV.O|Verve Therapeutics|20240116|12.54|185|